Targeting Ketone Body Metabolism Improves Cardiac Function and Hemodynamics in Patients With Heart Failure: A

Tingting Lv1,2, Chunyan Liu3, Shitian Guo4

  • 1Department of General Practice, Shaoxing People's Hospital, Shaoxing 312000, P. R. China.

Nutrition Reviews
|January 28, 2025
PubMed

Insights

Ketone therapy significantly improves heart function and blood flow in heart failure patients. This intervention also benefits individuals without heart failure, suggesting broad therapeutic potential.

Area of Science:

  • Cardiology
  • Metabolic Medicine
  • Pharmacology

Background:

  • The impact of elevated ketone bodies on cardiac function and hemodynamics in heart failure (HF) patients is not well understood.
  • Existing research has not quantitatively assessed the effects of ketone interventions in HF populations.

Purpose of the Study:

  • To quantitatively evaluate the effects of ketone intervention on cardiac function and hemodynamics in patients with heart failure through a meta-analysis.
  • To explore the potential benefits of ketone therapy in both HF and non-HF populations.

Main Methods:

  • A systematic literature search was conducted across PubMed, Cochrane Library, and Embase databases up to April 13, 2024.
  • Studies involving ketone ester and β-hydroxybutyrate interventions in humans were included.
  • Seven human studies were quantitatively analyzed to assess the impact of ketone therapy.

Main Results:

  • Ketone therapy significantly improved left ventricular ejection fraction, cardiac output, and stroke volume in HF patients.
  • Systemic vascular resistance was significantly reduced by ketone therapy, while mean arterial pressure remained unaffected.
  • Subgroup analysis indicated that these positive effects on cardiac function and hemodynamics were also observed in individuals without HF.

Conclusions:

  • Ketone therapy demonstrates significant potential to enhance cardiac systolic function and improve hemodynamics in patients with heart failure.
  • The findings suggest that ketone therapy is a promising treatment strategy for heart failure.
  • Ketone therapy may also serve as a beneficial medical strategy for individuals without heart failure and healthy individuals.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
324
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
547
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
620
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K